ASTRO Virtual Meeting Center

Log-in / Create Account

Session Information

2010 Multidisciplinary Head and Neck Cancer Symposium

Click here to go to the previous page

Meet the Professors: Conversations on Oropharyngeal Cancer

Track : Breakfast Sessions

Program Code: 06

Date: Friday, February 26, 2010

Time: 7:00 AM to 8:00 AM EST

Duration: 60 Minutes

Location: Kave 1-2 Ballroom

MODERATOR:

Click the plus sign to see more detailed information about each speaker.

David Raben, M.D., Radiation Oncologist, University of Colorado Comprehensive Cancer Center

SPEAKER(S):

Click the plus sign to see more detailed information about each speaker.

Heiko Schoder, M.D., Professor, Memorial Sloan-Kettering Cancer Center

David Adelstein, M.D., Professor, Cleveland Clinic Foundation

I have been a medical oncologist with a focus on the management of aerodigestive tract cancer for the past 25 years. Recent publications: 1. Adelstein DJ, Rice TW, Rybicki LA, Saxton JP, Videtic GMM, Murthy SC, Zuccaro G, Vargo JJ, Dumot JA, Carroll MA: A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: The impact of clinical heterogeneity. American Journal of Clinical Oncology 30:172-180, 2007. 2. Tan A, Adelstein DJ, Rybicki LA, Saxton JP, Esclamado RM, Wood BG, Lorenz RR, Strome M, Carroll MA: Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy. Archives of Otolaryngology Head and Neck Surgery 133:435-440, 2007. 3. Adelstein DJ: Concurrent chemoradiotherapy in the management of squamous cell cancer of the oropharynx: Current standards and future directions. International Journal of Radiation Oncology, Biology, Physics 69(Suppl.):S37-S39, 2007. 4. Kalmadi SR, Rankin C, Flaherty LE, Jacobs AD, Petrylak DP, Adelstein DJ, Keohan ML, Taub RN, Borden EC: Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: A phase II study of the Southwest Oncology Group (SWOG 9810). Lung Cancer 2008 (in press). 5. Adelstein, DJ, Rodriguez CP: Current and emerging standards of concomitant chemoradiotherapy. Seminars in Oncology 35:211-220, 2008 6. Rodriguez CP, Adelstein DJ, Rybicki LA, Saxton JP, Lorenz RR, Wood BG, Strome M, Esclamado RM, Lavertu P, Carroll MA: Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy. Head and Neck (in press) 7. Mackley HB, Adelstein JS, Reddy CA, Adelstein DJ, Rice TW, Saxton JP, Videtic GMM: Does radiation planning modality impact outcomes in the treatment of locally advanced esophageal cancer? American Journal of Clinical Oncology (in press).

Michael Kupferman, M.D., M.D. Anderson Cancer Center

David Raben, M.D., Radiation Oncologist, University of Colorado Comprehensive Cancer Center

Audio Synchronized to PowerPoint

(Code: 06)

Member:

Members Login